239 related articles for article (PubMed ID: 22659843)
1. Phospho-specific Smad3 signaling: impact on breast oncogenesis.
Tarasewicz E; Jeruss JS
Cell Cycle; 2012 Jul; 11(13):2443-51. PubMed ID: 22659843
[TBL] [Abstract][Full Text] [Related]
2. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
3. Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells.
Bae E; Sato M; Kim RJ; Kwak MK; Naka K; Gim J; Kadota M; Tang B; Flanders KC; Kim TA; Leem SH; Park T; Liu F; Wakefield LM; Kim SJ; Ooshima A
Cancer Res; 2014 Nov; 74(21):6139-49. PubMed ID: 25205100
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.
Hiemer SE; Szymaniak AD; Varelas X
J Biol Chem; 2014 May; 289(19):13461-74. PubMed ID: 24648515
[TBL] [Abstract][Full Text] [Related]
5. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.
Tarasewicz E; Rivas L; Hamdan R; Dokic D; Parimi V; Bernabe BP; Thomas A; Shea LD; Jeruss JS
Cell Cycle; 2014; 13(20):3191-201. PubMed ID: 25485498
[TBL] [Abstract][Full Text] [Related]
7. Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.
Chen X; Cao X; Sun X; Lei R; Chen P; Zhao Y; Jiang Y; Yin J; Chen R; Ye D; Wang Q; Liu Z; Liu S; Cheng C; Mao J; Hou Y; Wang M; Siebenlist U; Eugene Chin Y; Wang Y; Cao L; Hu G; Zhang X
Cell Death Dis; 2016 Dec; 7(12):e2508. PubMed ID: 27906182
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
9. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
10. Modulation of TGFβ/Smad signaling by the small GTPase RhoB.
Livitsanou M; Vasilaki E; Stournaras C; Kardassis D
Cell Signal; 2018 Aug; 48():54-63. PubMed ID: 29705334
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.
Cherlet T; Murphy LC
Mol Cell Biochem; 2007 Dec; 306(1-2):33-42. PubMed ID: 17660955
[TBL] [Abstract][Full Text] [Related]
12. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
13. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
15. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
16. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
Dzwonek J; Preobrazhenska O; Cazzola S; Conidi A; Schellens A; van Dinther M; Stubbs A; Klippel A; Huylebroeck D; ten Dijke P; Verschueren K
Mol Cancer Res; 2009 Aug; 7(8):1342-53. PubMed ID: 19671686
[TBL] [Abstract][Full Text] [Related]
17. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
[TBL] [Abstract][Full Text] [Related]
18. Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer.
Soond SM; Smith PG; Wahl L; Swingler TE; Clark IM; Hemmings AM; Chantry A
Biochim Biophys Acta; 2013 Dec; 1832(12):2127-35. PubMed ID: 23938591
[TBL] [Abstract][Full Text] [Related]
19. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]